charge amounts – Talk Bio

Actionable Insights Powered by AI

Sanofi’s E. coli Vaccine Fails Phase 3 Trial, Resulting in $250M Impairment Charge

4 months ago talkbio0Tagged charge amounts, Clinical Trials, Escherichia coli, Failure (biologic function), Impaired, Johnson & Johnson, Phase 3, sanofi, Vaccines

Sanofi, Johnson & Johnson, E. coli vaccine, Phase 3 failure, impairment charge, clinical trial discontinuation

AstraZeneca Discontinues Vemircopan, Takes $753M Charge on Former Alexion Asset

4 months ago talkbio0Tagged Alexion, AstraZeneca, charge amounts, Complement Inactivating Agents, drug discontinuation, Drug Industry, Impaired, Vemircopan

AstraZeneca, Alexion, vemircopan, complement inhibitor, drug discontinuation, impairment charge, rare diseases, pharmaceutical industry

Cassava Sciences Agrees to $40 Million Settlement with SEC Over Manipulated Alzheimer’s Trial Data

8 months ago talkbio0Tagged Alzheimer 's drug, charge amounts, Clinical Trials, Manihot esculenta, seconds, Settlement and Resettlement, Simufilam, statements

Cassava Sciences, SEC charges, Alzheimer’s drug, simufilam, manipulated trial data, settlement, misleading statements

Revolutionizing Biotherapeutic Analysis: Novel icIEF Fractionation and Mass Spectrometry for Charge Characterization

1 year ago talkbio0Tagged analytical techniques, Biological Factors, biotherapeutics, Characterization, charge amounts, Chemical fractionation, Imaged Capillary Isoelectric Focusing, Protein Analysis, protein charge, Protein Purification, protein separation, therapeutic protein, Variant

biotherapeutics, icIEF fractionation, mass spectrometry, charge characterization, protein analysis, therapeutic proteins, biopharmaceuticals, analytical techniques, protein purification, protein separation, protein charge variants.